Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is a major cause of death in patients with severe CO...
Alternative Titles
Full title
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4e5f454090e447f9aeb0c7a9c96a9a8c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e5f454090e447f9aeb0c7a9c96a9a8c
Other Identifiers
ISSN
2054-9369,2095-7467
E-ISSN
2054-9369
DOI
10.1186/s40779-020-00247-7
